PSCA Antibody (YA3543)

Cat. No.: HY-P83846: Data Sheet COA
SDS
User Guide for Antibodies
FAQs
Technical Support

PSCA Antibody (YA3543) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to PSCA.

For research use only. We do not sell to patients.

Size	Stock	Quantity
20 μL	In-stock	Estimated Time of Arrival: December 31
50 μL	In-stock	Estimated Time of Arrival: December 31
100 μL	In-stock	Estimated Time of Arrival: December 31
250 μL	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

PSCA Antibody (YA3543) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to PSCA.

Host

Mouse

Clonality

Monoclonal

Molecular Weight

Predicted band size: 12 kDa;

Observed band size: 12 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human

SwissProt ID

O43653

Gene ID

8000 [NCBI]

Immunogen

Purified recombinant fragment of human PSCA (AA: 1-114) expressed in E. Coli.

Application &
Dilution Ratio

Application	Dilution Ratio
ICC/IF ICC/IF: Immunocytochemistry/Immunofluorescence	1:200-1:1000
FC FC: Flow Cytometry	1:200-1:400
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:10000

Purity	affinity purified.	Conjugation	Non-conjugated
Modification	Unmodified	Isotype	IgG2a

Appearance

Liquid

Formulation

Supplied in PBS with 0.05% sodium azide

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：May be involved in the regulation of cell proliferation. Has a cell-proliferation inhibition activity in vitro; May act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits nicotine-induced signaling probably implicating alpha-3:beta-2- or alpha-7-containing nAChRs

Subcellular Localization：Cell membrane; Lipid-anchor, GPI-anchor

Expression：
Tissue_specificity:It is highly expressed in the prostate (basal epithelial cells, secretory epithelial cells, and neuroendocrine epithelial cells) . It is also found in the bladder (transitional epithelium) , placenta (trophoblast cells) , stomach (neuroendocrine cells) , colon (neuroendocrine cells) , and kidney (collecting ducts) . It is overexpressed in prostate cancer, and its expression is correlated with tumor stage, grade, and androgen-independent characteristics. It is highly expressed in bone metastases of prostate cancer. It is expressed in gastric epithelial cells, primarily in the gastric isthmus (protein level) . It is not detected in normal intestinal epithelium (protein level) . It is expressed in the cerebral cortex; its expression is significantly increased in the prefrontal cortex of Alzheimer's disease patients.

Induction:Down-regulated in gastric cancer cells

Subunit：Interacts with CHRNA4

Synonyms

PRO232

Documentation

Select Batch:

Data Sheet (234 KB) SDS (251 KB)

COA (205 KB)

User Guide for Antibodies (1077 KB)